Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation

- Hill, Timothy A., Stewart, Scott G., Ackland, Stephen P., Gilbert, Jayne, Sauer, Benjamin, Sakoff, Jennette A., McCluskey, Adam

Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines

- McCluskey, Adam, Ackland, Stephen P., Bowyer, Michael C., Baldwin, Monique L., Garner, James, Walkom, Cecilia C., Sakoff, Jennette A.

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer

- Wong, Mark, Balleine, Rosemary L., Hoskins, Janelle M., Mann, Graham J., Clarke, Christine L., Gurney, Howard, Blair, Elaine Y. L., McLachlan, Andrew J., Ackland, Stephen P., Garg, Madhu B., Evans, Scott, Farlow, David, Collins, Michael, Rivory, Laurent P.

Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A

- McCluskey, Adam, Walkom, Cecilia, Bowyer, Michael C., Ackland, Stephen P., Gardiner, Emma, Sakoff, Jennette A.

Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition

- Hill, Timothy A., Stewart, Scott G., Gordon, Christopher P., Ackland, Stephen P., Gilbert, Jayne, Sauer, Benjamin, Sakoff, Jennette A., McCluskey, Adam

Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer

- Stockler, Martin R., Harvey, Vernon J., Gainford, M. Corona, Fong, Akiko, Paksec, Lisa, Sourjina, Tatiana, Zannino, Diana, Gebski, Val, Simes, R. John, Forbes, John F., Coates, Alan S., Francis, Prudence A., Byrne, Michael J., Ackland, Stephen P., Fitzharris, Bernie, Van Hazel , Guy, Wilcken, Nicholas R. C., Grimison, Peter S., Nowak, Anna K.

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

- Tebbutt, Niall C., Wilson, Kate, Forgeson, Garry, Cunningham, David, Saunders, Mark P., Stockler, Martin R., Chua, Yujo, Zalcberg, John R., Simes, R. John, Price, Timothy J., Gebski, Val J., Cummins, Michelle M., Zannino, Dianna, van Hazel, Guy A., Robinson, Bridget, Broad, Adam, Ganju, Vinod, Ackland, Stephen P.

Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect

- Garg, Madhu B., Ackland, Stephen P.

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

- Goldstein, David, Gainford, M Corona, Miller, Danielle, Shannon, Jenny, Brown, Chris, Tebbutt, Niall, Ackland, Stephen P., van Hazel, Guy, Jefford, Michael, Abdi, Ehtesham, Selva-Nayagam, Sid, Gebski, Val

Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity

- Hill, Timothy A., Stewart, Scott G., Sauer, Benjamin, Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam

Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity

- Stewart, Scott G., Hill, Timothy A., Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam

Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition

- Sakoff, Jennette A., Howitt, Ian J., Ackland, Stephen P., McCluskey, Adam

A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients

- Garg, Madhu B., Sakoff, Jennette A., Ackland, Stephen P.

Current opinion on optimal treatment for colorectal cancer

- Price, Timothy J., Segelov, Eva, Shapiro, Jeremy D., Burge, Matthew, Haller, Daniel G., Ackland, Stephen P., Tebbutt, Niall C., Karapetis, Christos S., Pavlakis, Nick, Sobrero, Alberto F., Cunningham, David

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

- Ngan, Samuel Y., Burmeister, Bryan, McKendrick, Joseph, Leong, Trevor, Hartopeanu, Cris, Zalcberg, John, Mackay, John, Fisher, Richard J., Solomon, Michael, Goldstein, David, Joseph, David, Ackland, Stephen P., Schache, David, McClure, Bev, McLachlan, Sue-Anne

Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial)

- Ackland, Stephen P., Bull, James M., Boyle, Frances M.

Collaborative patient-centered quality improvement: a cross-sectional survey comparing the types and numbers of quality initiatives selected by patients and health professionals

- Fradgley, Elizabeth A., Paul, Christine L., Bryant, Jamie, Collins, Nicolas, Ackland, Stephen P., Bellamy, Douglas, Levi, Christopher R.

Oncology patients overwhelmingly support tissue banking

- Bryant, Jamie, Sanson-Fisher, Rob, Fradgley, Elizabeth, Regan, Timothy, Hobden, Breanne, Ackland, Stephen P.

The impact on health-related quality of life in the first 12 months: a randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)

- McLachlan, Sue-Anne, Fisher, Richard J., MacKay, John, Ngan, Samuel Y., Zalcberg, John, Solomon, Michael, Burmeister, Bryan, Goldstein, David, Leong, Trevor, Ackland, Stephen P., McKendrick, Joseph, McClure, Bev